Journal Watch · Cell Reports · 2026
Histamine H3 receptors in the paraventricular thalamus link sleep loss to fat overconsumption.
Collectively, our findings reveal PVT-H<sub>3</sub>R signaling as a critical pathway converting circadian disruption to fat-specific hyperphagia, offering more therapeutic targets for precise body-weight management.
TL;DR
Collectively, our findings reveal PVT-H<sub>3</sub>R signaling as a critical pathway converting circadian disruption to fat-specific hyperphagia, offering more therapeutic targets for precise body-weight management.
Key findings
- Importantly, overexpressing PVT H<sub>3</sub>Rs or inhibiting β-arrestin locally rescues the SR-induced HFDP.
- Collectively, our findings reveal PVT-H<sub>3</sub>R signaling as a critical pathway converting circadian disruption to fat-specific hyperphagia, offering more therapeutic targets for precise body-weight management.
What they did
Supportively, chemogenetic manipulations of PVT neurons bidirectionally regulate SR-induced HFDP. Further ultra-trace protein detection shows that histamine H3 receptor (H<sub>3</sub>R) expression negatively correlates with overconsumption. SR triggers local histamine accumulation in the PVT, which downregulates H<sub>3</sub>Rs via the β-arrestin pathway.
Full abstract (original)
Background: Sleep loss promotes obesity, yet the neural mechanisms linking disrupted sleep patterns to abnormal feeding behaviors remain unclear. By integrating the UK Biobank cohort analyses with mouse sleep restriction (SR) models, we demonstrate that insufficient sleep selectively increases high-fat diet (HFD) preference (HFDP), without affecting standard chow or high-sugar consumption. Whole-brain c-Fos mapping and in vitro electrophysiological techniques reveal reduced excitability of glutamatergic neurons in the paraventricular thalamus (PVT) following SR.
What they did: Supportively, chemogenetic manipulations of PVT neurons bidirectionally regulate SR-induced HFDP. Further ultra-trace protein detection shows that histamine H3 receptor (H<sub>3</sub>R) expression negatively correlates with overconsumption. SR triggers local histamine accumulation in the PVT, which downregulates H<sub>3</sub>Rs via the β-arrestin pathway.
Results & conclusions: Importantly, overexpressing PVT H<sub>3</sub>Rs or inhibiting β-arrestin locally rescues the SR-induced HFDP. Collectively, our findings reveal PVT-H<sub>3</sub>R signaling as a critical pathway converting circadian disruption to fat-specific hyperphagia, offering more therapeutic targets for precise body-weight management.
Abstract © the authors / Cell Reports (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.celrep.2026.116967 · PubMed 41671083.
Why it matters for pharma & biotech
- Relevant to Biology & Life Sciences teams tracking Cell Reports for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Cell Reports study find?
Collectively, our findings reveal PVT-H<sub>3</sub>R signaling as a critical pathway converting circadian disruption to fat-specific hyperphagia, offering more therapeutic targets for precise body-weight management.
What type of study is this?
It is a cohort / observational clinical study, published in Cell Reports in 2026. Supportively, chemogenetic manipulations of PVT neurons bidirectionally regulate SR-induced HFDP.
Where can I read the original paper?
The original is at the publisher via DOI 10.1016/j.celrep.2026.116967. PubMed ID: 41671083. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/histamine-h3-receptors-in-the-paraventricular-thalamus-link-sleep-loss-t-116967/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides